Home
 

Scientist Profiles

Ingrid Oakley-Girvan, Ph.D., M.P.H.
Research Scientist, Cancer Prevention Institute of California

Consulting Assistant Professor, Division of Epidemiology, Dept. of Health Research & Policy, Stanford University School of Medicine
Member, Stanford Cancer Institute

2201 Walnut Avenue, Suite 300
Fremont, California 94538-2334
E-mail: Ingrid.Oakley-Girvan@CPIC.org
Phone: 510-608-5045
Fax: 510-608-5085

Research Interests:

  • Evaluating factors associated with racial disparities in prostate and breast cancer diagnosis, progression and survival
  • Evaluating genetic factors and gene/environment interactions involved in prostate and breast cancer incidence, progression and survival
  • Evaluating genetic factors and gene/environment interactions involved in ovarian cancer incidence and survival
  • Assessing quality of life and survivorship issues two or more years after diagnosis

Dr. Oakley-Girvan's research concentrates on studies of breast, ovarian and prostate cancer with an emphasis on genetic epidemiology and survivorship.

Genetic epidemiology: Identifying genes that increase susceptibility to cancer or are related to poor survival is a primary interest of Dr. Oakley-Girvan. She is part of the International Consortium for Prostate Cancer Genetics and a member in an international breast and ovarian cancer research group. Through these collaborative teams, which include a broad base of investigators from many institutions and genetic samples from many projects, Dr. Oakley-Girvan is able to focus on investigating genes that may increase a person's susceptibility to prostate, ovarian and breast cancer. In addition, she aims to identify environmental factors that reduce an individual's risk of these cancers, as well as decrease their risk of cancer recurrence and improve their chance of survival.

Survivorship: Dr. Oakley-Girvan is also actively evaluating factors associated with cancer treatment choice, quality of care, treatment outcomes and quality of life. With interests throughout the cancer survivorship continuum and an emphasis on understanding why there are disparities in survivor care, Dr. Oakley-Girvan is also focused on creating solutions. She plans to follow her current studies with education and intervention projects that will effect meaningful change, improve the life of survivors and help eliminate, or, at the very least, reduce cancer health care disparities.

Selected Research Projects:


All Research Projects


Selected Research Publications:

Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Grönberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, Fitzgerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB; International Consortium for Prostate Cancer Genetics. Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCGProstate. 2011 Jul 11. doi: 10.1002/pros.21443. [Epub ahead of print].

Bloom JR, Stewart SL, Oakley-Girvan I, Banks PJ, Shema S. Quality of life of younger breast cancer survivors: persistence of problems and sense of well-being. Psychooncology. 2011 May 2. [Epub ahead of print].

Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. JCO. 2011;29(10):1280-9.

Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol. 2010;184(1):120-5.

Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL. Physicians' decision-making style and psychosocial outcomes among cancer survivors.Patient Educ Couns. 2009;77(3):404-12.

Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiol Biomarkers Prev. 2008;17(1):252-4.

All Publications (40)


Education:

INSTITUTION AND LOCATION DEGREE, YEAR FIELD OF STUDY
Stanford University Ph.D.  2002 Epidemiology
Tulane University School of Public Health M.P.H.  1992 Epidemiology
University of Michigan, Ann Arbor B.S.  1987 Biology



Professional Memberships, Professional Activities, and Awards:

1997-2002 NCI Cancer Training Grant, Stanford University
1992  Cancer Association of New Orleans Student Research Grant
1992  Founders' Academic Scholarship, Zeta Tau Alpha Sorority
1991-1992  Deans' Grant, School of Public Health, Tulane University
1987 Order of Omega Honor Society, University of Michigan


Web site Links:

Stanford website for Dr. Oakley-Girvan:
http://med.stanford.edu/profiles/Ingrid_Oakley-Girvan/

 

Back to Scientist Profiles.

Back to Top